Fluorescence analysis of competition of phenylbutazone and methotrexate in binding to serum albumin in combination treatment in rheumatology

Huang, 2004, J. Am. Soc. Mass. Spectrom., 15, 1237, 10.1016/j.jasms.2004.05.004

Sudlow, 1975, Mol. Pharmacol., 11, 824

Carter, 1994, Adv. Protein Chem., 45, 153, 10.1016/S0065-3233(08)60640-3

Peters, 1996

Kragh-Hansen, 2002, Biol. Pharm. Bull., 25, 695, 10.1248/bpb.25.695

Dockal, 2000, Protein Sci., 9, 1455, 10.1110/ps.9.8.1455

Petitpas, 2001, J. Biol. Chem., 276, 22804, 10.1074/jbc.M100575200

Bhattacharya, 2000, J. Biol. Chem., 275, 38731, 10.1074/jbc.M005460200

Carter, 1990, Science, 249, 302, 10.1126/science.2374930

Sułkowska, 2007, J. Mol. Struct., 834–836, 162, 10.1016/j.molstruc.2006.10.058

Bojko, 2008, Int. J. Biol. Macromol., 42, 314, 10.1016/j.ijbiomac.2007.11.002

Eftink, 1976, J. Phys. Chem., 80, 486, 10.1021/j100546a014

Sułkowska, 2008, J. Mol. Struct., 881, 97, 10.1016/j.molstruc.2007.09.001

Valeur, 2002

Hiratsuka, 1990, J. Biol. Chem., 265, 18786, 10.1016/S0021-9258(17)30581-1

Zhu-Sheng, 2002, Chem. Pharm. Bull., 50, 1017, 10.1248/cpb.50.1017

Takeda, 1997, Biophys. Chem., 69, 175, 10.1016/S0301-4622(97)00084-7

Lehrer, 1971, Biochemistry, 10, 3254, 10.1021/bi00793a015

Eftink, 1976, Biochemistry, 15, 672, 10.1021/bi00648a035

Eftink, 1981, Anal. Biochem., 114, 199, 10.1016/0003-2697(81)90474-7

Claudepierre, 1994, Biochem. Pharmacol., 47, 415, 10.1016/0006-2952(94)90034-5

Lakowicz, 2006

Watt, 1979, J. Biol. Chem., 254, 1684, 10.1016/S0021-9258(17)37827-4

Claudepierre, 1994, Int. J. Clin. Pharmacol. Ther., 32, 113

Wunder, 2003, J. Immunol., 170, 4793, 10.4049/jimmunol.170.9.4793

Elewaut, 2004, Rheumatology, 43, 1067, 10.1093/rheumatology/keh242

Fiehn, 2004, Rheumatology, 43, 1097, 10.1093/rheumatology/keh254

Sweeney, 2006, Clin. Cancer Res., 12, 536, 10.1158/1078-0432.CCR-05-1834

Thyss, 1986, Lancet, 1, 256, 10.1016/S0140-6736(86)90786-5

Nozaki, 2004, JPET, 309, 226, 10.1124/jpet.103.061812